Acquired TTP is postulated to be secondary to viral infections that trigger the production of autoantibodies targeted against ADAMTS13 [48]. A small proportion of TTP cases are attributable to congenital disease, with low ADAMTS13 activity (<10%) and no detectable antibody, confirmed by mutational analyses. Here, ADAMTS13 is linked to thrombotic thrombocytopenic purpura.